Drugs@FDA: FDA-Approved Drugs
Abbreviated New Drug Application (ANDA): 214588
Company: ALEMBIC
Company: ALEMBIC
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
BEPOTASTINE BESILATE | BEPOTASTINE BESILATE | 1.5% | SOLUTION/DROPS;OPHTHALMIC | Prescription | AT | No | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
04/05/2023 | ORIG-1 | Approval | STANDARD |
Label is not available on this site. |
BEPOTASTINE BESILATE
SOLUTION/DROPS;OPHTHALMIC; 1.5%
TE Code = AT
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | RLD | TE Code | Application No. | Company |
---|---|---|---|---|---|---|---|---|
BEPOTASTINE BESILATE | BEPOTASTINE BESILATE | 1.5% | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AT | 214588 | ALEMBIC |
BEPOTASTINE BESILATE | BEPOTASTINE BESILATE | 1.5% | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AT | 206066 | APOTEX |
BEPOTASTINE BESILATE | BEPOTASTINE BESILATE | 1.5% | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AT | 206220 | MYLAN |
BEPOTASTINE BESILATE | BEPOTASTINE BESILATE | 1.5% | SOLUTION/DROPS;OPHTHALMIC | Prescription | No | AT | 217770 | SOMERSET THERAPS LLC |
BEPREVE | BEPOTASTINE BESILATE | 1.5% | SOLUTION/DROPS;OPHTHALMIC | Prescription | Yes | AT | 022288 | BAUSCH AND LOMB INC |